Trial intelligence / Profile preview

Humoral Immune Response Against Mosquito Salivary Antigens (SG6)

NCT04478370Completed

Sponsor
University of Oxford
Start
Jan 2021
Primary completion
Jul 2025
Countries
1
01

Overview

Randomised, open-label trial (5 arms), sponsored by University of Oxford. Primary endpoints: Levels of specific antibody titers against candidate peptides at day 112, Kinetics of specific antibody titers against candidate peptides at day 112 and 1 more. Started Jan 2021; status: completed.

Beyond the preview

Go deeper on NCT04478370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04478370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call